Logo image of ISGI.CA

INSURAGUEST TECHNOLOGIES INC (ISGI.CA) Stock Fundamental Analysis

TSX-V:ISGI - CA4578001006 - Common Stock

0.025 CAD
0 (-16.67%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

2

ISGI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. The financial health of ISGI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ISGI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ISGI had negative earnings in the past year.
ISGI had a negative operating cash flow in the past year.
In the past 5 years ISGI always reported negative net income.
ISGI had a negative operating cash flow in each of the past 5 years.
ISGI.CA Yearly Net Income VS EBIT VS OCF VS FCFISGI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -103.15%
ROE -1959.05%
ROIC N/A
ROA(3y)-220.5%
ROA(5y)-303.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISGI.CA Yearly ROA, ROE, ROICISGI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

1.3 Margins

In the last couple of years the Gross Margin of ISGI has grown nicely.
ISGI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5YN/A
ISGI.CA Yearly Profit, Operating, Gross MarginsISGI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

4

2. Health

2.1 Basic Checks

ISGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
ISGI has more shares outstanding than it did 1 year ago.
ISGI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ISGI is higher compared to a year ago.
ISGI.CA Yearly Shares OutstandingISGI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ISGI.CA Yearly Total Debt VS Total AssetsISGI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

2.2 Solvency

ISGI has an Altman-Z score of -22.91. This is a bad value and indicates that ISGI is not financially healthy and even has some risk of bankruptcy.
ISGI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -22.91
ROIC/WACCN/A
WACC10.1%
ISGI.CA Yearly LT Debt VS Equity VS FCFISGI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K -1M -1.5M

2.3 Liquidity

A Current Ratio of 1.01 indicates that ISGI should not have too much problems paying its short term obligations.
ISGI has a Quick Ratio of 1.01. This is a normal value and indicates that ISGI is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
ISGI.CA Yearly Current Assets VS Current LiabilitesISGI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

4

3. Growth

3.1 Past

ISGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.03%, which is quite impressive.
ISGI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.08%.
The Revenue has been growing by 86.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y86.01%
Revenue growth 5YN/A
Sales Q2Q%-10.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ISGI.CA Yearly Revenue VS EstimatesISGI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ISGI.CA Price Earnings VS Forward Price EarningsISGI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISGI.CA Per share dataISGI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 -0 0 0.01 0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ISGI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSURAGUEST TECHNOLOGIES INC

TSX-V:ISGI (8/22/2025, 7:00:00 PM)

0.025

0 (-16.67%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners63.35%
Ins Owner ChangeN/A
Market Cap4.26M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.91
P/FCF N/A
P/OCF N/A
P/B 132.07
P/tB 155.54
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.15%
ROE -1959.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.57%
FCFM N/A
ROA(3y)-220.5%
ROA(5y)-303.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5YN/A
F-Score5
Asset Turnover2.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z -22.91
F-Score5
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.08%
Revenue growth 3Y86.01%
Revenue growth 5YN/A
Sales Q2Q%-10.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.03%
OCF growth 3YN/A
OCF growth 5YN/A